NeuropsychopharmacologyJuly 15, 2025Maria Beatriz Bistue Millón, Laura Noguera, Diana Bruno et al.4 citations
This Phase I clinical trial is the first to rigorously evaluate the safety, tolerability, and pharmacokinetics of a novel sublingual formulation of 5-MeO-DMT, administered at sub-psychedelic doses to adults with moderate to high levels of anxiety and/or depression, without formal psychiatric diagnosis or ongoing treatment. Using a double-blind, placebo-controlled design, participants received a...
Most of the literature that has emerged about the impacts of home isolation during the COVID-19 pandemic suggests it causes mildly to acutely adverse psychosocial and physiological responses, particularly in children. Such responses relate to the separation children experience from their normal routine, including loneliness, anxiety, and depression, and adversities associated with school...
Schools in Perú have not typically been the sites of research on meditation or its possible role in student health or primary and secondary education outcomes. This retrospective observational study seeks to begin redressing this evidentiary shortfall by confirming results from an earlier, smaller-scale study of 91 students in Huay-Huay, with a specific focus on the practice of Transcendental...